Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glypican 2 as a cancer marker and therapeutic target

Glypican 2 as a cancer marker and therapeutic target

US Patent 11814440 · Granted Nov 14, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) a2025
Compositions and methods for treating cancer with anti-BCMA immunotherapy2025
Compositions and methods for treating cancer with anti-CD38 immunotherapy2025
Compositions and methods for treating cancer with anti-CD38 immunotherapy2025
ADAM17 binding molecules and uses thereof2025
ADAM17 binding molecules and uses thereof2025
Methods and compositions for use of tumor self-antigens in adoptive immunotherap2025
Compositions and methods for treating cancer with anti-CD123 immunotherapy2024
Compositions and methods for treating cancer with anti-CD123 immunotherapy2024
Human monoclonal antibodies against EphA4 and their use2024
Methods of treatments using antigen-binding proteins targeting CD562024
Human monoclonal antibodies specific for FLT3 and uses thereof2024